A Study of TQ-B3525 on Tolerance and Pharmacokinetics

Clinical trial NCT03510767 · UNKNOWN

Trial details

NCT number: NCT03510767
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed or Refractory Lymphoma or Advanced Cancer

Start date: 2018-06-20
Primary completion: 2022-08-15
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.